Follow The Filings

NXTC Nextcure Inc.

Health Care, filed as NEXTCURE INC (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 exit

In 2026 Q2 James Silverman sold out of Nextcure.

Who owns NXTC

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management exited 2026 Q2 Last 2026 Q1 0.20% Exit −0.20% 141,181 $1.5M History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by NXTC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NXTC insider trades
  • $1.8M bought by 1 insider
  • $185K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $54K 10,851 shares at $4.95 +1.5% to stake
    Traded Oct 23–27 Filed Oct 27
    ↗
  2. Simcere Zaiming, Inc. Insider, +5 joint filers
    Sale
    $185K 30,000 shares at $6.16 8.9% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  3. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $1.6M 329,153 shares at $4.93 +84% to stake
    Traded Jul 30–31 Filed Aug 3
    ↗
  4. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $88K 17,608 shares at $4.98 +4.7% to stake
    Traded Jul 27–29 Filed Jul 29
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.05,5.01,5.02,7.01,8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A FORM DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$62.72M -$55.65M -$55.84M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $112.72M $71.81M $43.75M
Total non-current assets * $15.31M $9.05M $6.44M
Total assets $128.04M $80.86M $50.18M
Total current liabilities $6.88M $9.57M $10.57M
Total non-current liabilities * $6.73M $5.81M $4.67M
Total equity $114.42M $65.47M $34.94M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$52.97M -$40.8M -$49.61M
Cash from investing $39.27M $55.31M $25.56M
Cash from financing $0.154M $0.144M $22.31M
Net change in cash -$13.55M $14.64M -$1.74M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.